IDEXX Laboratories Director Daniel M. Junius Files Form 144 to Sell $345.8K in Stock
IDEXX LABORATORIES INC /DE
Subscribe to track IDXX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š Form 144 Notice of Proposed Sale: IDEXX LABORATORIES INC /DE ($IDXX) ā¢ Insider: Daniel M. Junius (Director) ā¢ Shares to Sell: 500 shares ($345,835 est. value at ~$691.67/share) ā¢ Broker: Fidelity Brokerage Services LLC ā¢ Approximate Date: 11/04/2026 ā¢ Note: Selling out of personal IRA; originally acquired via open market purchase in August 2015. ā¢ Significance: Low (<0.01% of outstanding shares)
Comprehensive Analysis
Transaction Overview
Director Daniel M. Junius has filed a Form 144 notice of proposed sale for 500 shares of IDEXX Laboratories Inc ($IDXX) common stock, representing an aggregate market value of approximately $345,835.00.
Key Details
- Insider: Daniel M. Junius, Director
- Filing Date: November 4, 2026
- Proposed Sale Date: November 4, 2026
- Security: Common Stock
- Volume: 500 shares
- Aggregate Value: $345,835.00 (~$691.67 per share)
- Shares Outstanding: 78,786,265
- Acquisition History: Originally acquired via open market purchase on August 3, 2015.
- Additional Remarks: Sale is being executed indirectly out of the insider's IRA account.
Significance
The trading significance is rated Low. The transaction volume of 500 shares represents less than 0.001% of IDEXX Laboratories' outstanding common stock and appears to be routine portfolio or retirement account rebalancing.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.